UBS Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $200K | Buy |
|
|||||
|
2024
Q1 | $1.33K | Sell |
|
|||||
|
2023
Q4 | $9.7K | Buy |
|
|||||
|
2023
Q3 | $307 | Sell |
|
|||||
|
2023
Q2 | $6.76K | Sell |
|
|||||
|
2023
Q1 | $16.9K | Sell |
|
|||||
|
2022
Q4 | $43.3K | Sell |
|
|||||
|
2022
Q3 | $700K | Buy |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $1.69M | Sell |
|
|||||
|
2021
Q4 | $2.63M | Buy |
|
|||||
|
2021
Q3 | $1.62M | Buy |
|
|||||
|
2021
Q2 | $335K | Sell |
|
|||||
|
2021
Q1 | $1.6M | Buy |
|
|||||
|
2020
Q4 | $4K | Sell |
|
|||||
|
2020
Q3 | $60K | Buy |
|
|||||
|
2020
Q2 | $38K | Sell |
|
|||||
|
2020
Q1 | $118K | Sell |
|
|||||
|
2019
Q4 | $725K | Sell |
|
|||||
|
2019
Q3 | $1.52M | Buy |
|
|||||
|
2019
Q2 | $524K | Buy |
|
|||||
|
2019
Q1 | $12K | Sell |
|
|||||
|
2018
Q4 | $1.8M | Buy |
|
|||||
|
2018
Q3 | $406K | Buy |
|
|||||
|
2018
Q2 | $95K | Buy |
|
|||||
|
2018
Q1 | $40K | Sell |
|
|||||
|
2017
Q4 | $27K | Buy |
|
|||||
|
2017
Q3 | $10K | Sell |
|
|||||
|
2017
Q2 | $15K | Buy |
|